ODonnell Kathleen M 4
4 · BIODELIVERY SCIENCES INTERNATIONAL INC · Filed Sep 24, 2004
Insider Transaction Report
Form 4
ODonnell Kathleen M
10% Owner
Transactions
- Purchase
Common Stock
[F1]2004-09-22$2.90/sh+100$290→ 127,500 total(indirect: By Trust) - Purchase
Common Stock
[F1]2004-09-22$2.90/sh+1,150$3,335→ 128,650 total(indirect: By Trust) - Purchase
Common Stock
[F1]2004-09-22$2.88/sh+100$288→ 128,750 total(indirect: By Trust) - Purchase
Common Stock
[F1]2004-09-22$2.88/sh+300$864→ 129,050 total(indirect: By Trust) - Purchase
Common Stock
[F1]2004-09-22$2.89/sh+850$2,457→ 129,900 total(indirect: By Trust)
Holdings
- 3,111,580(indirect: By Hopkins Capital Group)
Common Stock
[F2] - 4,577
Common Stock
- 35,000(indirect: By Trust)
Warrants
[F1]Exercise: $6.33From: 2003-06-24Exp: 2007-06-24→ Common Stock (5,000 underlying) - 294,118(indirect: By Hopkins Capital Group)
Series B Preferred Stock
[F3][F4]From: 2004-08-24→ Common Stock (294,118 underlying)
Footnotes (4)
- [F1]Held by the Francis E. O'Donnell Irrevocable Trust #1, of which reporting party is Trustee
- [F2]Held by Hopkins Capital Group II, LLC, which is one third owned by the Francis E. O'Donnell Irrevocable Trust #1, of which the reporting party is Trustee
- [F3]Not applicable
- [F4]Held by Hopkins Capital Group II, LLC, which is one third owned by the Francis E. O'Donnell Irrevocable Trust #1, of which the reporting party is Trustee. The Series B Preferred Stock is convertible on a one for one basis
Signature
Kathleen M. O'Donnell|2004-09-24